AstraZeneca Sponsorship of cfDNA testing for EGFR mutations in Lung Cancer EQA

Posted 1/04/2020

We are delighted to announce that AstraZeneca have agreed to fund laboratory participation in the EQA through the provision of an unrestricted educational grant. Participation will in the EQA will therefore be FREE.

If you have already registered for the EQA then we will credit your account to ensure that participation costs are withdrawn.  If you have NOT registered, please log in to your account and enrol for the scheme. The closing date has been extended to 30th April 2020.

Capacity is capped at 300 laboratories and we only less than 100 spaces left so please register quickly if you want to guarantee your place on the EQA.

Go to top